Biochemical diagnosis of liver disease

Indian Journal of Clinical Biochemistry

Volumn 14, Issue 1, 1999, Pages 59-90

  Wolf, Paul L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Albumin; Alkaline phosphatase and transaminases; Bilirubin; Liver function tests

Indexed keywords

EID: 0346078408     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02869152     Document Type: Review

References (66)

1. Tygstrup, N. (1990) Assessment of liver function: Principles and practice. J. Gastroenterol. Hepatol. 5, 468-682.
2. Corless, J.K. and Middleton, H.M. III. (1983) Normal liver function: A basis for understanding hepatic disease. Arch. Intern. Med. 143, 2291-2294.
3. Skrede, S., Solberg, H.E., Ritland, S., Blomhoff, J.P., Schrumpf, E., Elgjo, K. and Gjone, E. (1982) Diagnostic and prognostic value of laboratory tests assessed in a follow-up study of 200 patients with liver disease. Clin. Chem. 28, 1177-1181.
4. Reichling, J.J. and Kaplan, M.M. (1988) Clinical use of serum enzymes in liver disease. Dig. Dis. Sci. 33, 1601-1614.
5. Killingsworth, L.M. (1979) Plasma protein patterns in health and disease. Crit. Rev. Clin. Lab. Sci. 11, 1-30.
6. Peters, T. Jr. (1975) Serum albumin. In: The -plasma proteins Ed. F. Putman, Academic Press, New York, USA, 2nd edn. Vol1. p. 133.
7. Pinnel, A.E. and Northam, B.E. (1978) New automated dye-binding method for serum albumin determination with bromcresol purple. Clin. Chem. 24, 80-86.
8. Blanchaert, M. (1980) Analysis of bilirubin and bilirubin mono-and di-conjugates. Biochem. J. 185, 115-128.
9. Doumas, B.T., Perry, B.W., Sasse, E.A. and Straumfjord, J.V. Jr. (1973) Standardization in bilirubin assays: Evaluation of selected methods and stability of bilirubin solutions. Clin.Chem.19, 984-993.
10. Lott, J.A. and Wolf, P.L. Alanine and aspartate aminotransferase (ALT and AST). In: Clin. Enzymql. Eds. Lott, J.A., Wolf, P.L., Yearbook Medical Publishers, Chicago, USA. 111-157.
11. Panteghini, M., Malechiodi, A., Calarco, M. and Bonora, R. (1984) Clinical and diagnostic significance of aspartate aminotransferase isoenzymes in sera of patients with liver diseases. J. Clin. Chem. Clin. Biochem. 22, 153-158.
12. DeRitis, F. and Cacciatora, L. (1983) Differential diagnosis of liver diseases. In: Clin. Hepatol. Ecis. Csomos. G., Thaler, H., Springer-Verlag, Berlin, Germany. 16-28.
13. Nalpas, B., Vassault, A. and LeGuilon, A. (1984) Serum activity of mitochondrial aspartate aminotransferase; a sensitive marker of alocoholism with or without alcoholic hepatitis. Hepatology. 4, 893-896.
14. Schmidt, E. and Schmidt, F.W. (1990) Progress in the enzyme diagnosis of liver disease; reality or illusion? Clin. Biochem. 23, 375-382.
15. Lott, J.A. and Landesman, P.W. (1984) The enzymology of skeletal muscle disorders. Crit. Rev. Clin. Lab. Sci. 20, 153-190.
16. Rosalki, S.B. (1989) Serum enzymes in disease of skeletal muscle. Clin. Lab. Med. 9, 767-781.
17. Wolf, P.L., Lott, J.A., Nitti, G.J. and Bookstein, R. (1987) Changes in serum enzymes, lactate and haptoglobin following acute physical stress in international class athletes. Clin. Biochem. 20, 73-77.
18. Wolf, P.L. (1994) Clinical significance of serum high-molecular-mass alkaline phosphatase, alkaline phosphatase-lipoprotein-x complex, and intestinal variant alkaline phosphatase. Jour. Clin. Lab. Anal. 81, 172-176.
19. Wolf, P.L.(1990) High-molecular-weight alkaline phosphatase and alkaline phosphatase lipoprotein x complex in cholestasis and hepatic malignancy. Arch. Pathol. Lab. Med. 114, 577-579.
20. Van Hoof, V. and DeBroe, M.E. (1994) Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit. Rev. Clin. Lab. Sci. 31(3), 197-293.
21. Wolf, P.L. (1978) Clinical significance of an increased or decreased serum alkaline phosphatase. Arch. Pathol. Lab. Med. 102, 497-501.
22. Birkett, D.J., Done, J., Neale, F.C. and Posen, S. (1966) Serum alkaline phosphatase in pregnancy; an immunological study. Br. Med. J. 1, 1210-1212.
23. Siraganian, P.A., Mulvihill, J.J., Mulivor, R.A. and Miller, R.W. (1989) Benign familial hyperphosphatasemia. J. Am. Med. Assoc. 261, 1310-1312.
24. Wolf, P.L. (1995) The significance of transient hyperphosphatasemia of infancy and childhood to the clinician and clinical pathologist. Arch. Pathol. Lab. Med. 119, 774-775.
25. Moss, D.W. (1982) Alkaline phosphatase isoenzymes. Clin. Chem. 28, 2007-2016.
26. Van Hoof, V.O., Lepoutre, L.G., Hoylaerts, M.F., Chevigne, R. and DeBroe, M.E. (1988) Improved agarose electrophoretic method for separating alkaline phosphatase isoenzymes in serum. Clin. Chem. 34, 1857-1862.
27. Rosalki, S.B., Foo, A.Y., Burlina, A., Prellwitz, W., Stieber, P., Neumeier, D., Klein, G., Poppe, W.A. and Bodenmuller, H. (1993) Multicentric evaluation of Iso-ALP test kit for measurement of bone alkaline phosphatase in serum and plasma. Clin. Chem. 39, 648-652.
28. Hill, C.S. and Wolfert, R.L. (1989) The preparation of monoclonal antibodies which react preferentially with human bone alkaline phosphatase and not liver alkaline phosphatase. Clin. Chim. Acta. 186, 315-320.
29. Bradbeer, J.N., Zanelli, J.M., Lindsay, P.C., Pearson, J. and Reeve, J. (1992) Relationship between the location of osteoblastic alkaline phosphatase activity and bone formation in human iliac crest bone. J. Bone Min. Res. 7, 905-912.
30. Moss, D.W. (1992) Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclasts and other macrophages. Clin. Chim. Acta. 209, 131-138.
31. Van Hoof, V.O., Van Oosterom, A.T., Lepoutre, L.G. and DeBroe, M.E. (1992) Alkaline phosphatase isoenzyme patterns in malignant disease. Clin. Chem. 38, 2546-2551.
32. Fishman, W.H., Inglis, N.R., Stolbach, L.L. and Krant, M.J. (1968) A serum alkaline phosphatase isoenzymes of human neoplastic cell origin. Cancer Res. 28, 150-154.
33. Nathanson, L. and Fishman, W. (1971) New observations on the Regan isoenzyme of alkaline phosphatase in cancer patients. Cancer 27, 1388-1397.
34. Stolbach, L, Krant, M. and Fishman, W. (1969) Ectopic production of alkaline phosphatase isoenzyme in patients with cancer. New Engl. J. Med. 281, 757-762.
35. Hada, T., Higashino, K., Okochi, T. and Yamamura, Y. (1978) Kasahara-variant alkaline phosphatase in renal cell carcinoma. Clin. Chim. Acta. 89, 311-316.
36. Tietz, N.W., Burtis, C.A., Duncan, P., Erwin, K., Petitclerc, C.J., Rinker, A.D., Shuey, D. and Zygowic, E.R. (1983) A reference m of gamma-glutamyl transferase. CRC Crit. Rev. Clin. Lab. Sci. 12, 1-58.
37. Burlina, A. (1978) Improved method of fractionating gamma-glutamyl transferase by electrophoresis on cellulose acetate. Clin. Chem. 24, 502-504.
38. Rosalki, S.B. and Rau, D. (1972) Serum gamma-glutamyl transpeptidase activity in alcoholism. Clin.; Chim. Acta. 39, 41-47.
39. Nemesanszky, E., Lott, J.A. and Arato, M. (1988) Changes in serum enzymes in moderate drinkers after an alcohol challenge. Clin. Chem. 34, 525-527.
40. Sacchetti, L., Castaldo, G. and Salvatore, F. (1988) The y-glutamyltransferase isoenzyme pattern in serum as a signal discriminating between hepatobiliary diseases, including neoplasias. Clin. Chem. 34, 352-355.
41. Eriksen, J., Olsen, P.S. and Thomsen, A.C. (1984) Gamma-glutamyl- transpeptidase, aspartate aminotransferase, and erythrocyte mean corpuscular volume as indicators of alcohol consumption in liver disease. Scand. J. Gastroenterol. 19, 813-819.
42. Acheampong-Mensah, D. (1976) Activity of gamma-glutamyl-transpeptidase in serum of patients receiving anticonvulsant or anticoagulant therapy. Clim. Biochem. 9, 67-70.
43. Rosalki, S.B., Tarlow, D. and Rau, D. (1971) Plasma gamma-glutamyl- transpeptidase elevation in patients receiving enzyme-inducing drugs. Lancet ii 376-377.
44. Cullen, D.R. and Goldberg, D.M. (1976) The association between serum triglycerides and GGT activity in diabetes mellitus. Clin. Biochem. 9, 208-211.
45. Humphries, B.A., Melnychuk, M., Donegan, E.J. and Snee, R.D. (1979) Automated enzymatic assay for plasma ammonia. Clin. Chem. 25, 26-30.
46. Mitchell, R.A., Partin, J.C., Partin, J.S. and Ram, M.L. (1985) Hepatic and encephalopathic components of Reye's syndrome: Factor analysis of admission data from 209 patients. Neurology. 35, 1236-1239.
47. Mondzac, A., Ehrlich, G.E. and Seegmiller, J.E., (1965) An enzymatic determination of ammonia in biological fluids. J. Lab. Clin. Med. 66, 526-531.
48. Shahangian, S., Ash, K.O., Wahlstrom, N.O. Jr., Warden, J.D., Saffle, J.R., Taylor, A. Jr. and Green, L.S. (1984) Creatine kinase and lactate dehydrogenase isoenzymes in serum of patients suffering burns, blunt trauma, or myocardial infarction. Clin. Chem. 30, 1332-1338.
49. Bruns, D.E., Savory, J. and Wills, M.R. (1984) More on "flipped" lactate dehydrogenase patterns in myocardial infarction. Clin. Chem. 30, 1881-1882.
50. Ketchum, C.H., Robinson, C.A., Hall, L.M. and Grizzle, W.E. (1984) Clinical significance and partial biochemical characterization of lactate dehydrogenase isoenzyme 6. Clin. Chem. 30, 46-49.
51. Wolf, P.L. (1985) Lactate dehydrogenase-6: A biochemical sign of serious hepatic circulatory disturbance. Arch. Intern. Med. 145, 1396-1397.
52. Kato, S., Ishii, H., Kano, S., Horii, K. and Tsuchiya, M. (1984) Evidence that "lactate dehydrogenase isoenzyme 6" is in fact alcohol dehydrogenase. Clin. Chem. 30, 1585-1586.
53. Gambiho, R. (1980) Wilson's disease, an early diagnosis is essential. Lab. Rep. Physic. 51-54.
54. Wolf, P.L., Ray, G. and Kaplan, H. (1979) Evaluation of copper oxidase (ceruloplasmin) and related tests in Hodgkin's disease. Clin. Biochem. 12, 202-204.
55. Wolf, P.L. (1982) Ceruloplasmin: Methods and clinical use. CRC Crit. Rev. Lab. Sci. 17, 229-245
56. Wolf, P.L., Enlander, D., Dalziel, J. and Swanson, J. (1969) Green plasma in blood donors. New Eng. Jour. Med. 281, 205-206.
57. Wald, N.J. and Cuckle, H.S. (1982) Nomogram for estimating an individual's risk of having a fetus with open spina bifida. Br. J. Obstet. Gynaecol. 89, 598-604
58. Wolf, P.L. (1996) In : Enzyme tests in body fluids other than blood and urine. Chapter 20 Amniotic Fluid in Enzyme Tests in Diagnosis. Moss, D.W. and Rosalki S.B. Eds. Edwards Arnold Publisher, London, U.K. p 270-271.
59. Balistreri, W.F., Suchy, F.J., Farrell, M.K. and Heubi, J.E. (1981) Pathologic versus physiologic cholestasis: Elevated serum concentration of a secondary bile acid in the presence of hepatobiliary disease. J.Pediatr. 98, 399-402.
60. Danielsson, H. and Sjovall, J. (1975) Bile acid metabolism. Ann. Rev. Biochem. 44, 233-253.
61. Bean, P., Liegmann, K., Lovli, T., Westby, C. and Sundrehagen, E. (1997) Semiautomated procedures for evaluation of carbohydrate-deficient transferrin in the diagnosis of alcohol abuse. Clin. Chem. 43, 6983-6989.
62. Stibler, H. (1991) Carbohydrate-deficient transferrin in serum; a new marker of potentially harmful alcohol consumption reviewed. Clin. Chem. 37, 2029-2037.
63. Anton, R. and Bean, P. (1994) Two methods for measuring carbohydrate-deficient transferrin in inpatient alcoholics and healthy controls compared. Clin. Chem. 40, 364-368.
64. Doyle, K.M., Cluette-Brown, J.E., Dube, O.M., Bernhardt, T.G., Morse, C.R. and Laposata, M. (1996) J. Am. Med. Assoc. 176, 1152-1156.
65. Doyle, K.M., Bird, D.A., al-Salihi, S., Hallag, Y., Cluete-Brown, J.E., Goss, K.A. and Laposata, M. (1994) Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res. 35, 428-437.
66. Betro, M.G. (1972) Significance of increased alkaline phosphatase and lactate dehydrogenase activities coincident with normal serum bilirubin. Clin. Chem. 18, 1429.